Dr. Matthew J. Smith, M.D.
Orthopedic Surgery (Orthopaedic Surgery Physician)
- Medicare participating
At a glance
- Medical school
- Creighton University School of Medicine (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 315
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: Creighton University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Orthopaedic Surgery Physician primary
MO license 2006023690
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Missouri Health Care Columbia, MO
- Lake Regional Health System Osage Beach, MO
- Bothwell Regional Health Center Sedalia, MO
Medical groups
- The Curators of the University of Missouri (1,131 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 315
- Services billed
- 565
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 152 | 128 |
| Established patient office or other outpatient visit, 20-29 minutes | 131 | 114 |
| New patient office or other outpatient visit, 45-59 minutes | 79 | 79 |
| Prosthetic repair of shoulder joint, total shoulder | 52 | 50 |
| Aspiration and/or injection of fluid from large joint | 29 | 28 |
| New patient office or other outpatient visit, 30-44 minutes | 19 | 19 |
| Established patient office or other outpatient visit, 10-19 minutes | 18 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Oxycodone Hcl Other prescribers in Columbia, MO | 28 |
| Cephalexin Other prescribers in Columbia, MO | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 35 payments worth $872,381 in total to this clinician.
| DePuy Synthes Products, Inc. | $605,064 |
|---|---|
| Ignite Orthopedics, LLC | $249,211 |
| Medical Device Business Services, Inc. | $16,361 |
| Elite Orthopedics, LLC | $1,634 |
| Stryker Corporation | $88.11 |
| Arthrex, Inc. | $24.00 |
| Royalty or License | $854,144 |
|---|---|
| Consulting Fee | $14,850 |
| Travel and Lodging | $2,570 |
| Food and Beverage | $818 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Ignite Orthopedics, LLC Mar 27, 2025 | Royalty or License stock Company’s descriptionDistributions for Shoulder Royalty and Milestones | $146,846 |
| DePuy Synthes Products, Inc. Jun 30, 2025 | Royalty or License INHANCE · Ortho-Shoulder | $114,189 |
| DePuy Synthes Products, Inc. Sep 24, 2025 | Royalty or License INHANCE · Ortho-Shoulder | $109,941 |
| DePuy Synthes Products, Inc. Mar 24, 2025 | Royalty or License INHANCE · Ortho-Shoulder | $109,535 |
| DePuy Synthes Products, Inc. Dec 29, 2025 | Royalty or License INHANCE · Ortho-Shoulder | $108,575 |
| Ignite Orthopedics, LLC Mar 25, 2025 | Royalty or LicenseCompany’s descriptionSSU Milestones, Ignite Shoulder Royalty 4Q24 - 3Q25 | $102,365 |
| DePuy Synthes Products, Inc. Jan 13, 2025 | Royalty or License INHANCE · Ortho-Shoulder | $83,851 |
| DePuy Synthes Products, Inc. Dec 22, 2025 | Royalty or License | $17,719 |
| DePuy Synthes Products, Inc. Sep 22, 2025 | Royalty or License | $15,962 |
| DePuy Synthes Products, Inc. Mar 19, 2025 | Royalty or License | $15,922 |
All 24 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| DePuy Synthes Products, Inc. Dec 29, 2025 | Royalty or License INHANCE · Ortho-Shoulder | $108,575 |
| DePuy Synthes Products, Inc. Dec 22, 2025 | Royalty or License | $17,719 |
| Medical Device Business Services, Inc. Dec 9, 2025 | Consulting Fee | $1,013 |
| Elite Orthopedics, LLC Nov 10, 2025 | Travel and Lodging travel to NAPLES, FL · in-kind Company’s descriptionTransfer of value related to products manufactured by Arthrex | $254 |
| Elite Orthopedics, LLC Nov 9, 2025 | Travel and Lodging travel to NAPLES, FL · in-kind Company’s descriptionTransfer of value related to products manufactured by Arthrex | $20.50 |
| Medical Device Business Services, Inc. Nov 4, 2025 | Consulting Fee | $675 |
| Elite Orthopedics, LLC Oct 14, 2025 | Travel and Lodging travel to FT. MYERS, FL · in-kind Company’s descriptionTransfer of value related to products manufactured by Arthrex | $1,069 |
| DePuy Synthes Products, Inc. Sep 24, 2025 | Royalty or License INHANCE · Ortho-Shoulder | $109,941 |
| DePuy Synthes Products, Inc. Sep 22, 2025 | Royalty or License | $15,962 |
| DePuy Synthes Products, Inc. Jun 30, 2025 | Royalty or License INHANCE · Ortho-Shoulder | $114,189 |
| DePuy Synthes Products, Inc. Jun 26, 2025 | Royalty or License | $13,871 |
| Ignite Orthopedics, LLC Mar 27, 2025 | Royalty or License stock Company’s descriptionDistributions for Shoulder Royalty and Milestones | $146,846 |
| Ignite Orthopedics, LLC Mar 25, 2025 | Royalty or LicenseCompany’s descriptionSSU Milestones, Ignite Shoulder Royalty 4Q24 - 3Q25 | $102,365 |
| DePuy Synthes Products, Inc. Mar 24, 2025 | Royalty or License INHANCE · Ortho-Shoulder | $109,535 |
| DePuy Synthes Products, Inc. Mar 19, 2025 | Royalty or License | $15,922 |
| Medical Device Business Services, Inc. Feb 18, 2025 | Consulting Fee | $9,450 |
| Medical Device Business Services, Inc. Feb 13, 2025 | Consulting Fee | $3,713 |
| Medical Device Business Services, Inc. Feb 10, 2025 | Travel and Lodging INHANCE · Ortho-Shoulder · travel to Tampa, FL · in-kind | $134 |
| Medical Device Business Services, Inc. Feb 9, 2025 | Travel and Lodging INHANCE · Ortho-Shoulder · travel to Tampa, FL · in-kind | $137 |
| Medical Device Business Services, Inc. Feb 8, 2025 | Travel and Lodging INHANCE · Ortho-Shoulder · travel to Tampa, FL · in-kind | $310 |
| Medical Device Business Services, Inc. Feb 7, 2025 | Travel and Lodging INHANCE · Ortho-Shoulder · travel to Tampa, FL · in-kind | $209 |
| DePuy Synthes Products, Inc. Jan 13, 2025 | Royalty or License INHANCE · Ortho-Shoulder | $83,851 |
| DePuy Synthes Products, Inc. Jan 13, 2025 | Royalty or License | $15,368 |
| Medical Device Business Services, Inc. Jan 13, 2025 | Travel and Lodging INHANCE · Ortho-Shoulder · travel to Tampa, FL · in-kind | $437 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $5,515 in research payments for these studies, mostly to the institutions running them.
- Pyrocarbon clinical follow-up study (20A-w-pyc-rm)
Stryker Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.